Potential role of microRNAs in personalized medicine against hepatitis: a futuristic approach
- 21 January 2024
- journal article
- review article
- Published by Springer Nature in Archives of Virology
- Vol. 169 (2) , 1-12
Abstract
MicroRNAs (miRNAs) have been the subject of extensive research for many years, primarily in the context of diseases such as cancer. However, our appreciation of their significance in viral infections, particularly in hepatitis, has increased due to the discovery of their association with both the host and the virus. Hepatitis is a major global health concern and can be caused by various viruses, including hepatitis A to E. This review highlights the key factors associated with miRNAs and their involvement in infections with various viruses that cause hepatitis. The review not only emphasizes the expression profiles of miRNAs in hepatitis but also puts a spotlight on their potential for diagnostics and therapeutic interventions. Ongoing extensive studies are propelling the therapeutic application of miRNAs, addressing both current limitations and potential strategies for the future of miRNAs in personalized medicine. Here, we discuss the potential of miRNAs to influence future medical research and an attempt to provide a thorough understanding of their diverse roles in hepatitis and beyond.Keywords
This publication has 83 references indexed in Scilit:
- Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotypeJournal of Hepatology, 2013
- Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease ProgressionPLOS ONE, 2013
- MicroRNA-146a Feedback Suppresses T Cell Immune Function by Targeting Stat1 in Patients with Chronic Hepatitis BThe Journal of Immunology, 2013
- Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?Gut, 2011
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # †Hepatology, 2009
- Engineering microRNA responsiveness to decrease virus pathogenicityNature Medicine, 2008
- Viral and Cellular MicroRNAs as Determinants of Viral Pathogenesis and ImmunityCell Host & Microbe, 2008
- Extrahepatic replication of HCV: Insights into clinical manifestations and biological consequencesHepatology, 2006
- The functions of animal microRNAsNature, 2004